Table 2 The antibiotic resistance and susceptibility profiles of ESBL E. cloace isolates from urine of patients suffering from UTIs
Antimicrobial drug | Concentration (µg) | Resistant | Susceptible | ||
|---|---|---|---|---|---|
Number of isolates | Percentage (%) | Number of isolates | Percentage (%) | ||
Ampicillin | 10 | 82 | 100 | 0 | 0.00 |
Amoxicillin–Clavulanate | 20/10 | 82 | 100 | 0 | 0.00 |
Cephalothin | 30 | 82 | 100 | 0 | 0.00 |
Cefuroxime | 30 | 66 | 80.49 | 16 | 19.51 |
Ceftazidime | 30 | 11 | 13.23 | 71 | 86.77 |
Cefoxitin | 30 | 80 | 97.56 | 2 | 2.44 |
Cefepime | 30 | 11 | 13.41 | 71 | 86.57 |
Cefotaxime | 30 | 19 | 23.17 | 63 | 76.83 |
Ceftriaxone | 30 | 19 | 23.17 | 63 | 76.83 |
Ciprofloxacin | 5 | 11 | 13.41 | 71 | 86.57 |
Gentamicin | 10 | 6 | 7.32 | 76 | 92.68 |
Amikacin | 30 | 0 | 0.00 | 82 | 100 |
Trimethoprim–Sulfamethoxazole | 1.25/23.75 | 19 | 23.17 | 63 | 76.83 |
Piperacillin-Tazobactam | 36 | 3 | 3.66 | 79 | 96.34 |
Imipenem | 10 | 3 | 3.66 | 79 | 96.34 |
Meropenem | 10 | 3 | 3.66 | 79 | 96.34 |
Ertapenem | 10 | 8 | 9.76 | 74 | 90.24 |
Levofloxacin | 5 | 3 | 3.66 | 79 | 96.34 |
Tigecycline | 15 | 11 | 13.41 | 71 | 86.57 |
Nitrofurantoin | 300 | 11 | 13.41 | 71 | 86.57 |
Aztreonam | 30 | 6 | 7.32 | 76 | 92.68 |